Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[The role of small bowel microflora in the development of secondary lactase deficiency and the possibilities of its treatment with probiotics].

Ruchkina IN, Fadeeva NA, Parfenov AI, Shcherbakov PL, Gubina AV, Poleva NI, Khomeriki SG, Chikunova BZ.

Ter Arkh. 2013;85(2):21-6. Russian.

PMID:
23653934
2.

[Lactase deficiency in patients with postinfectious irritable bowel syndrome and the role of intestinal microflora in its development].

Shcherbakova PL, Parfenov AI, Ruchkina IN, Fadeeva NA, Gubina AV, Melik-Agadzhanian NB, Poleva NI, Khomeriki SG, Chikunova BZ.

Eksp Klin Gastroenterol. 2012;(5):91-8. Russian.

PMID:
23402179
3.

[Small intestinal bacterial overgrowth as a cause of lactase deficiency].

Fadeeva NA, Ruchkina IN, Parfenov AI, Shcherbakov PL.

Ter Arkh. 2015;87(2):20-23. doi: 10.17116/terarkh201587220-23. Russian.

PMID:
25864343
4.

The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.

Mann NS, Limoges-Gonzales M.

Hepatogastroenterology. 2009 May-Jun;56(91-92):718-21.

PMID:
19621689
5.

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A.

Aliment Pharmacol Ther. 2005 Jun 1;21(11):1391-5.

6.

A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance.

Furnari M, Bonfanti D, Parodi A, Franzè J, Savarino E, Bruzzone L, Moscatelli A, Di Mario F, Dulbecco P, Savarino V.

J Clin Gastroenterol. 2013 Feb;47(2):148-52. doi: 10.1097/MCG.0b013e31824e9132.

PMID:
22495813
7.

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.

J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.

PMID:
22157240
8.

Lactose malabsorption, irritable bowel syndrome and self-reported milk intolerance.

Vernia P, Di Camillo M, Marinaro V.

Dig Liver Dis. 2001 Apr;33(3):234-9.

PMID:
11407668
9.

Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients.

Almeida CC, Lorena SL, Pavan CR, Akasaka HM, Mesquita MA.

Nutr Clin Pract. 2012 Apr;27(2):247-51. doi: 10.1177/0884533612440289. Epub 2012 Mar 8.

PMID:
22402407
10.

Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.

Weinstock LB, Geng B, Brandes SB.

Can J Urol. 2011 Aug;18(4):5826-30.

PMID:
21854715
11.

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.

Dig Liver Dis. 2007 Jun;39(6):530-6. Epub 2007 Apr 8.

PMID:
17420159
12.

Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.

Wedlake L, Thomas K, McGough C, Andreyev HJ.

Eur J Cancer. 2008 Oct;44(15):2212-7. doi: 10.1016/j.ejca.2008.07.018. Epub 2008 Aug 27.

PMID:
18760593
13.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

14.

The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial.

Ojetti V, Gigante G, Gabrielli M, Ainora ME, Mannocci A, Lauritano EC, Gasbarrini G, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):163-70.

PMID:
20391953
15.
16.

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.

Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.

Aliment Pharmacol Ther. 2008 Oct 15;28(8):994-1002. doi: 10.1111/j.1365-2036.2008.03818.x. Epub 2008 Jul 30.

17.

Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth.

Almeida JA, Kim R, Stoita A, McIver CJ, Kurtovic J, Riordan SM.

Scand J Gastroenterol. 2008;43(2):146-54. doi: 10.1080/00365520701676617.

PMID:
18224561
18.

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.

Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):48-57. Epub 2007 Oct 5.

19.

Proton pump inhibitors, irritable bowel syndrome, and small intestinal bacterial overgrowth: coincidence or Newton's third law revisited?

Chey WD, Spiegel B.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):480-2. doi: 10.1016/j.cgh.2010.03.002. Epub 2010 Mar 19. No abstract available.

PMID:
20304096
20.

Role of gut microflora and probiotic effects in the irritable bowel syndrome.

Fanigliulo L, Comparato G, Aragona G, Cavallaro L, Iori V, Maino M, Cavestro GM, Soliani P, Sianesi M, Franzè A, Di Mario F.

Acta Biomed. 2006 Aug;77(2):85-9.

PMID:
17172187

Supplemental Content

Support Center